cannabis use disorder phenotype
Evidence from:
primary |
all sources
Related entities (67)
Mentioned in (45)
Papers in which this entity is mentioned.
- Mapping the genetic landscape across 14 psychiatric disorders. (2026)
- Pervasive Downward Bias in Estimates of Liability-Scale Heritability in Genome-wide Association Study Meta-analysis: A Simple Solution. (2023)
- Depression pathophysiology, risk prediction of recurrence and comorbid psychiatric disorders using genome-wide analyses. (2023)
- Multi-ancestry study of the genetics of problematic alcohol use in over 1 million individuals. (2023)
- Associations Between Cannabis Use, Polygenic Liability for Schizophrenia, and Cannabis-related Experiences in a Sample of Cannabis Users. (2023)
- Compromised interhemispheric transfer of information partially mediates cognitive function deficits in adolescents with fetal alcohol syndrome. (2022)
- Multi-trait genome-wide association study of opioid addiction: OPRM1 and beyond. (2022)
- Item-Level Genome-Wide Association Study of the Alcohol Use Disorders Identification Test in Three Population-Based Cohorts. (2022)
- Multi-environment gene interactions linked to the interplay between polysubstance dependence and suicidality. (2021)
- Bi-ancestral depression GWAS in the Million Veteran Program and meta-analysis in >1.2 million individuals highlight new therapeutic directions. (2021)
- Occipital neural dynamics in cannabis and alcohol use: independent effects of addiction. (2021)
- Shared genetic risk between eating disorder- and substance-use-related phenotypes: Evidence from genome-wide association studies. (2021)
- Genetics of substance use disorders in the era of big data. (2021)
- Genome-wide association analysis of opioid use disorder: A novel approach using clinical data. (2020)
- Sibling comparisons elucidate the associations between educational attainment polygenic scores and alcohol, nicotine and cannabis. (2020)
- Exploring the relationship between polygenic risk for cannabis use, peer cannabis use and the longitudinal course of cannabis involvement. (2019)
- Psychosocial moderation of polygenic risk for cannabis involvement: the role of trauma exposure and frequency of religious service attendance. (2019)
- Mega-Analysis of Gray Matter Volume in Substance Dependence: General and Substance-Specific Regional Effects. (2019)
- A randomized controlled trial of screening and brief interventions for substance misuse in reproductive health. (2018)
- Genome-wide association study identifies a novel locus for cannabis dependence. (2018)
- Intersection of stress and gender in association with transitions in past year DSM-5 substance use disorder diagnoses in the United States. (2018)
- Review: Prevalence and co-occurrence of addictions in US ethnic/racial groups: Implications for genetic research. (2017)
- Age trends in rates of substance use disorders across ages 18-90: Differences by gender and race/ethnicity. (2017)
- Phenotypic and familial associations between childhood maltreatment and cannabis initiation and problems in young adult European-American and African-American women. (2017)
- Genome-wide Association Study of Cannabis Dependence Severity, Novel Risk Variants, and Shared Genetic Risks. (2016)
- Age at first use and later substance use disorder: Shared genetic and environmental pathways for nicotine, alcohol, and cannabis. (2016)
- Prevalence of Marijuana Use Disorders in the United States Between 2001-2002 and 2012-2013. (2015)
- Cannabis controversies: how genetics can inform the study of comorbidity. (2014)
- A survey of synthetic cannabinoid consumption by current cannabis users. (2014)
- A genetic perspective on the proposed inclusion of cannabis withdrawal in DSM-5. (2013)
- Prevalence of DSM-IV and DSM-5 alcohol, cocaine, opioid, and cannabis use disorders in a largely substance dependent sample. (2013)
- Childhood sexual abuse and early substance use in adolescent girls: the role of familial influences. (2013)
- Age of alcohol and cannabis use onset mediates the association of transmissible risk in childhood and development of alcohol and cannabis disorders: evidence for common liability. (2013)
- Common liability to addiction and "gateway hypothesis": theoretical, empirical and evolutionary perspective. (2012)
- The co-occurring use and misuse of cannabis and tobacco: a review. (2012)
- Psychiatric 'diseases' versus behavioral disorders and degree of genetic influence. (2011)
- Opioid dependence latent structure: two classes with differing severity? (2011)
- Pharmacological treatment of cannabis dependence. (2011)
- White matter fiber degradation attenuates hemispheric asymmetry when integrating visuomotor information. (2010)
- From child maltreatment to adolescent cannabis abuse and dependence: a developmental cascade model. (2010)
- Prenatal alcohol exposure and interhemispheric transfer of tactile information: Detroit and Cape Town findings. (2009)
- Altered white matter integrity in adolescent binge drinkers. (2009)
- Cannabis withdrawal in the United States: results from NESARC. (2008)
- Toward DSM-V: an item response theory analysis of the diagnostic process for DSM-IV alcohol abuse and dependence in adolescents. (2008)
- Short scales to assess cannabis-related problems: a review of psychometric properties. (2008)
Merged raw entities (12)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| cannabis use disorder | phenotype | 43 | 134 |
| cannabis use disorders | phenotype | 3 | 5 |
| cannabis-dependent participants | cohort | 2 | 2 |
| cannabis use disorder (cud) | phenotype | 2 | 2 |
| cuds | phenotype | 2 | 4 |
| cud diagnosis | phenotype | 1 | 2 |
| cud severity | phenotype | 1 | 2 |
| dsm-5 cannabis use disorder | phenotype | 1 | 1 |
| cannabis disorder | phenotype | — | — |
| dsm-5 cud symptom counts | phenotype | — | — |
| dsm-iv cud symptom counts | phenotype | — | — |
| ongoing cud | phenotype | — | — |